For people and families managing type 2 diabetes across Africa, finding the right prescribed medicine can sometimes involve more than simply visiting a local pharmacy. Availability, product authenticity, prescription requirements, storage conditions and cross-border sourcing can all become important considerations.
One medicine that is increasingly discussed in diabetes care is Ozempic, which contains the active ingredient semaglutide. In Europe, Ozempic is authorised for adults with insufficiently controlled type 2 diabetes, alongside diet and exercise. It is available as a solution for injection in a pre-filled pen and is used once weekly according to the prescribing healthcare professional’s instructions.
For customers researching Ozempic 0.25 mg and 1 mg, understanding the difference between strengths, how the medicine is used, and why medical supervision matters is an important first step.
What is Ozempic?
Ozempic is a prescription medicine containing semaglutide. Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists.
According to the European Medicines Agency, Ozempic is used together with diet and exercise to treat adults with type 2 diabetes whose blood glucose is not adequately controlled. It may be used on its own when metformin is unsuitable because of intolerance or contraindications, or alongside other diabetes medicines.
Semaglutide works by acting in a similar way to the naturally occurring hormone GLP-1. It helps increase insulin release when blood glucose is elevated and contributes to blood-glucose regulation.
It is important to distinguish Ozempic from medicines specifically authorised for weight management. Ozempic’s European indication is type 2 diabetes; patients should therefore speak with a qualified healthcare professional about which treatment is appropriate for their individual circumstances.
Understanding Ozempic 0.25 mg and 1 mg
The strengths of Ozempic can cause confusion, particularly for someone seeing different products or prescriptions online.
The 0.25 mg dose is used as the starting dose in the European dosing schedule. The current product information states that Ozempic is started at 0.25 mg once weekly, with the dose increased to 0.5 mg after four weeks. If additional blood-glucose control is needed, the dose may subsequently be increased to 1 mg after at least four weeks on 0.5 mg. The 0.25 mg dose is specifically described as a starting dose rather than a maintenance dose.
The 1 mg strength is therefore not simply a larger version that every patient should begin with. The appropriate dose depends on the treatment plan established by the prescribing healthcare professional.
This is why customers searching for Ozempic 0.25 mg and 1 mg should not choose a strength based only on availability, previous experience or advice from another person.
How is Ozempic administered?
Ozempic is administered once weekly as a subcutaneous injection. The European product information specifies injection into the abdomen, thigh or upper arm. It should not be administered intravenously or intramuscularly.
A healthcare professional should explain how the pre-filled pen should be used before treatment begins.
The weekly schedule can make treatment easier to incorporate into an established routine, but patients should follow the exact instructions provided with their prescription and product packaging.
If there is uncertainty about the correct dose, injection technique, missed dose or combination with another diabetes medicine, the appropriate step is to consult a doctor or pharmacist rather than making an adjustment independently.
Why the source of a medicine matters
For customers ordering healthcare products internationally, the source of a medicine deserves particular attention.
A medicine’s packaging, manufacturer information, batch details, expiry date, storage conditions and supply chain can all matter when assessing whether a product is appropriate for a patient’s prescribed treatment.
This becomes especially important when medicines are being sourced across borders. Customers in Nigeria, Ghana, South Africa, Egypt, Senegal, Morocco, Algeria and other African markets may encounter differences in local availability and distribution.
Apotekan focuses on helping customers access healthcare products sourced through European companies, pharmacies and licensed suppliers. Our approach is centred on sourcing and coordination rather than presenting Apotekan as a pharmacy.
You can learn more about our approach to authentic European healthcare products in our guide on identifying genuine European healthcare products.
Ozempic and storage: an important consideration
Ozempic requires appropriate storage.
The current European product information states that unopened Ozempic pens should be stored in a refrigerator at 2°C–8°C and should not be frozen. The pen should also be protected from light. After first opening, the permitted in-use storage period depends on the specific pen presentation.
This is particularly relevant when arranging international healthcare sourcing.
A medicine that requires controlled storage should not simply be treated like an ordinary parcel. Temperature, handling, packaging and delivery arrangements should be considered when planning an international order.
For customers in African countries, this is one reason it is useful to work with a sourcing service that understands the practical requirements involved in obtaining healthcare products from Europe.
Who should discuss Ozempic with a healthcare professional?
Ozempic is a prescription medicine. It is not appropriate for everyone with high blood glucose, and the decision to use it should be made by a qualified healthcare professional.
A doctor or pharmacist can consider factors such as:
- The individual’s diabetes treatment plan
- Other medicines currently being used
- Previous reactions to medicines
- Relevant medical history
- The appropriate dose and timing
- Whether additional monitoring is required
- How the medicine should be stored and handled
The European product information also contains important warnings and precautions, including considerations involving gastrointestinal effects, dehydration, diabetic retinopathy and pancreatitis. Patients should read the official product information and discuss relevant concerns with their healthcare professional.
Common questions about Ozempic 0.25 mg and 1 mg
Is 0.25 mg the regular long-term dose?
No. Under the European dosing schedule, 0.25 mg is the starting dose used during the first four weeks. It is not a maintenance dose.
Is 1 mg suitable for everyone?
No. The appropriate dose is determined as part of an individual’s treatment plan. A patient should not move from one strength to another without medical advice.
How often is Ozempic used?
Ozempic is administered once weekly according to the prescribed treatment plan.
Is Ozempic insulin?
No. Ozempic contains semaglutide and is not insulin. It belongs to the GLP-1 receptor agonist class of medicines.
Can I order Ozempic without a prescription?
Ozempic is a prescription medicine. Apotekan should not be used as a substitute for a doctor, pharmacist or other qualified healthcare professional. Customers should have the appropriate prescription and comply with the medicine and importation requirements applicable in their country.
Can Apotekan help customers in Africa source European healthcare products?
Apotekan helps customers coordinate access to healthcare products sourced from European companies, pharmacies and suppliers. For medicine requests, availability and fulfilment depend on the specific product, prescription requirements and applicable regulations.
Customers can visit Apotekan to explore available healthcare products or contact the Apotekan team about a specific sourcing request.
A more informed approach to international medicine sourcing
For someone researching Ozempic 0.25 mg and 1 mg, the most important question should not simply be where the medicine can be found. It should also be whether the product is appropriate for the patient’s prescription, whether it comes through a reliable supply chain, and whether it can be transported and stored correctly.
For families and patients across Nigeria, Ghana, South Africa, Egypt, Senegal, Morocco, Algeria and other African countries, international sourcing can sometimes provide an additional route for finding specific European healthcare products when local availability is limited.
Apotekan’s role is to make that sourcing process more organised by connecting customers with healthcare products from European sources and helping coordinate individual requests where permitted.
If you have a valid prescription and are looking for a specific European healthcare product, you can visit Apotekan or explore our Ozempic 1 mg product page for current product information.
Important: This article is for general educational purposes and does not replace medical advice, a diagnosis or a prescription. Ozempic should be used only as directed by a qualified healthcare professional. Availability, prescription requirements, import rules and delivery options can vary between African countries. Always check the requirements that apply in your country before arranging an international medicine order.